Authors:
van der Vliet, HJJ
von Blomberg, BME
Nishi, N
Reijm, M
Voskuyl, AE
van Bodegraven, AA
Polman, CH
Rustemeyer, T
Lips, P
van den Eertwegh, AJM
Giaccone, G
Scheper, RJ
Pinedo, HM
Citation: Hjj. Van Der Vliet et al., Circulating V alpha 24(+) V beta 11(+) NKT cell numbers are decreased in awide variety of diseases that are characterized by autoreactive tissue damage, CLIN IMMUNO, 100(2), 2001, pp. 144-148
Authors:
Ferreira, CG
van der Valk, P
Span, SW
Ludwig, I
Smit, EF
Kruyt, FAE
Pinedo, HM
van Tinteren, H
Giaccone, G
Citation: Cg. Ferreira et al., Expression of X-linked inhibitor of apoptosis as a novel prognostic markerin radically resected non-small cell lung cancer patients, CLIN CANC R, 7(8), 2001, pp. 2468-2474
Authors:
Ferreira, CG
van der Valk, P
Span, SW
Jonker, JM
Postmus, PE
Kruyt, FAE
Giaccone, G
Citation: Cg. Ferreira et al., Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients, ANN ONCOL, 12(6), 2001, pp. 799-805
Authors:
Backus, HHJ
Dukers, DF
van Groeningen, CJ
Vos, W
Bloemena, E
Wouters, D
van Riel, JMGH
Smid, K
Giaccone, G
Pinedo, HM
Peters, GJ
Citation: Hhj. Backus et al., 5-Fluorouracil induced Fas upregulation associated with apoptosis in livermetastases of colorectal cancer patients, ANN ONCOL, 12(2), 2001, pp. 209-216
Authors:
Huisman, C
Postmus, PE
Giaccone, G
Smit, EF
Citation: C. Huisman et al., A phase I study of sequential intravenous topotecan and etoposide in lung cancer patients, ANN ONCOL, 12(11), 2001, pp. 1567-1573
Authors:
Tjan-Heijnen, VCG
Postmus, PE
Ardizzoni, A
Manegold, C
Burghouts, J
van Meerbeeck, J
Gans, S
Mollers, M
Buchholz, E
Biesma, B
Legrand, C
Debruyne, C
Giaccone, G
Citation: Vcg. Tjan-heijnen et al., Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study, ANN ONCOL, 12(10), 2001, pp. 1359-1368
Authors:
Peters, GJ
van Groeningen, CJ
Giaccone, G
Citation: Gj. Peters et al., Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor, J CL ONCOL, 19(22), 2001, pp. 4267-4268
Authors:
Huisman, C
Giaccone, G
van Groeningen, CJ
Sutedja, G
Postmus, PE
Smit, EF
Citation: C. Huisman et al., Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling, LUNG CANC, 33(2-3), 2001, pp. 267-275
Authors:
Dingemans, AMC
van Ark-Otte, J
Span, S
Scagliotti, GV
van der Valk, P
Postmus, PE
Giaccone, G
Citation: Amc. Dingemans et al., Topoisomerase II alpha and other drug resistance markers in advanced non-small cell lung cancer, LUNG CANC, 32(2), 2001, pp. 117-128
Authors:
Takao, M
Ghetti, B
Murrell, JR
Unverzagt, FW
Giaccone, G
Tagliavini, F
Bugiani, O
Piccardo, P
Hulette, CM
Crain, BJ
Farlow, MR
Heyman, A
Citation: M. Takao et al., Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures, J NE EXP NE, 60(12), 2001, pp. 1137-1152
Authors:
van der Vliet, HJJ
Nishi, N
Koezuka, Y
von Blomberg, BME
van den Eertwegh, AJM
Porcelli, SA
Pinedo, HM
Scheper, RJ
Giaccone, G
Citation: Hjj. Van Der Vliet et al., Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15, J IMMUNOL M, 247(1-2), 2001, pp. 61-72
Authors:
Tagliavini, F
Lievens, PMJ
Tranchant, C
Warter, JM
Mohr, M
Giaccone, G
Perini, F
Rossi, G
Salmona, M
Piccardo, P
Ghetti, B
Beavis, RC
Bugiani, O
Frangione, B
Prelli, F
Citation: F. Tagliavini et al., A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Straussler-Scheinker disease A117V, J BIOL CHEM, 276(8), 2001, pp. 6009-6015
Authors:
Sorbi, S
Alberoni, M
Alfieri, P
Vesuviana, S
Amici, S
Antana, D
Appollonio, I
Avanzi, S
Bartoli, A
Bergamasco, B
Bracco, L
Bruni, A
Terme, L
Bugiani, O
Caffarra, P
Caltagirone, C
Carolei, A
Casini, AR
Ciannella, L
Citterio, A
Daniele, A
D'Achille, G
Del Curatolo, G
Dell'Agnello, G
Durante, D
Farina, E
Ferrero, P
Forleo, P
Gainotti, G
Gabriele, P
Galante, E
Gallai, V
Gallassi, R
Gasparini, M
Ghetti, B
Giaccone, G
Girotti, F
Grimaldi, L
Grioli, S
Guarnieri, BM
Grottoli, S
Iemolo, F
Latorraca, S
Le Pira, F
Lenzi, GL
Lorusso, S
Mariani, C
Marcon, G
Mascia, V
Mearelli, S
Morante, M
Morbin, M
Musicco, M
Nardelli, E
Nichelli, P
Padovani, A
Paganini, M
Pantieri, R
Parisen, P
Parnetti, L
Passerella, B
Pettenati, C
Piacentini, S
Piccoli, F
Piccolini, C
Pizzolato, G
Provinciali, L
Pugliese, N
Redi, F
Ruggieri, RM
Ruggiero, U
Saetta, M
Schoenuber, R
Silveri, MC
Sorbi, S
Sorrentino, G
Sucapane, P
Stracciari, A
Tabaton, M
Tagliavini, F
Toso, V
Valluzzi, F
Citation: S. Sorbi et al., Guidelines for the diagnosis of dementia and Alzheimer's disease, NEUROL SCI, 21(4), 2000, pp. 187-194
Authors:
Ferreira, CG
Tolis, C
Span, SW
Peters, GJ
van Lopik, T
Kummer, AJ
Pinedo, HM
Giaccone, G
Citation: Cg. Ferreira et al., Drug-induced apoptosis in lung cancer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway, CLIN CANC R, 6(1), 2000, pp. 203-212
Authors:
Giaccone, G
Canciani, B
Puoti, G
Rossi, G
Goffredo, D
Iussich, S
Fociani, P
Tagliavini, F
Bugiani, O
Citation: G. Giaccone et al., Creutzfeldt-Jakob Disease: Carnoy's fixative improves the immunohistochemistry of the proteinase K-resistant prion protein. (vol 10, pg 31, 2000), BRAIN PATH, 10(2), 2000, pp. 326-329
Authors:
Giaccone, G
Canciani, B
Puoti, G
Rossi, G
Goffredo, D
Iussich, S
Fociani, P
Tagliavini, F
Bugiani, O
Citation: G. Giaccone et al., Creutzfeldt-Jakob disease: Carnoy's fixative improves the immunohistochemistry of the proteinase K-resistant prion protein, BRAIN PATH, 10(1), 2000, pp. 31-37
Authors:
van Moorsel, CJA
Pinedo, HM
Smid, K
Comijn, EM
Voorn, DA
Veerman, G
Lakerveld, B
Van der Vijgh, WJF
Giaccone, G
Postmus, PE
Peters, GJ
Citation: Cja. Van Moorsel et al., Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin inmice bearing Lewis lung murine non-small cell lung tumours, EUR J CANC, 36(18), 2000, pp. 2420-2429
Authors:
Bergman, AM
Giaccone, G
van Moorsel, CJA
Mauritz, R
Noordhuis, P
Pinedo, HM
Peters, GJ
Citation: Am. Bergman et al., Cross-resistance in the 2 ',2 '-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs, EUR J CANC, 36(15), 2000, pp. 1974-1983
Authors:
Terwogt, JMM
van Tellingen, O
Panday, VRN
Huizing, MT
Schellens, JHM
Huinink, WWT
Boschma, MUS
Giaccone, G
Veenhof, CHN
Beijnen, JH
Citation: Jmm. Terwogt et al., Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol (R))and carboplatin in non-small cell lung cancer patients, ANTI-CANC D, 11(9), 2000, pp. 687-694